Community-acquired pneumonia (CAP) is a costly disease that is associated with significant
morbidity and mortality. The growing prevalence of this disease has resulted in various …

Community-acquired pneumonia (CAP) is a common and serious problem in the United
States, and the sixth leading cause of death in those over age 65. Not only has short-term …

In 2019, guidelines for the management of immunocompetent adults with community-
acquired pneumonia (CAP) were published jointly by the American Thoracic Society and the …

Community-acquired pneumonia (CAP) is a common disorder that is potentially life-
threatening, especially in older adults and patients with comorbid disease. Despite …

Community-acquired pneumonia (CAP) is a common illness, with the majority of patients
treated out of the hospital, yet the greatest burden of the cost of care comes from inpatient …

Community-Acquired Pneumonia (CAP) refers to pneumonia acquired outside of hospitals
or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia …

Published guidelines for community-acquired pneumonia (CAP) have informed
management and treatment recommendations for 25 years. Since inception, CAP guidelines …

Pneumonia remains a serious medical problem, and its diagnosis and management is the
source of considerable controversy. To date, 3 sets of guidelines have been published in …

Community-acquired pneumonia (CAP) is a common and potentially serious illness with
significant human and economic costs to society. The recent collaborative statement from …

Community-acquired pneumonia (CAP) is a leading cause of death in the world and the
sixth most common cause of death in the United States. It is the number one cause of death …